PAX Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,963
Closed -$381K 230
2024
Q3
$381K Buy
1,963
+107
+6% +$22.4K 0.07% 190
2024
Q2
$430K Sell
1,856
-97
-5% -$21.1K 0.08% 181
2024
Q1
$421K Buy
1,953
+156
+9% +$36.5K 0.08% 184
2023
Q4
$432K Buy
1,797
+220
+14% +$54K 0.09% 178
2023
Q3
$405K Buy
1,577
+45
+3% +$12K 0.09% 172
2023
Q2
$436K Sell
1,532
-61
-4% -$18.2K 0.1% 171
2023
Q1
$443K Sell
1,593
-41
-3% -$11.3K 0.11% 160
2022
Q4
$452K Sell
1,634
-1,035
-39% -$292K 0.11% 142
2022
Q3
$713K Sell
2,669
-44
-2% -$9.35K 0.18% 90
2022
Q2
$553K Sell
2,713
-723
-21% -$148K 0.14% 126
2022
Q1
$724K Buy
3,436
+286
+9% +$62.2K 0.17% 107
2021
Q4
$756K Buy
3,150
+424
+16% +$109K 0.17% 108
2021
Q3
$771K Sell
2,726
-7
-0.3% -$2.29K 0.19% 89
2021
Q2
$946K Buy
2,733
+67
+3% +$20.3K 0.24% 55
2021
Q1
$746K Buy
2,666
+499
+23% +$135K 0.21% 71
2020
Q4
$531K Buy
2,167
+347
+19% +$89.5K 0.17% 85
2020
Q3
$516K Buy
1,820
+352
+24% +$98.2K 0.18% 77
2020
Q2
$393K Buy
1,468
+246
+20% +$73.9K 0.15% 93
2020
Q1
$364K Buy
1,222
+304
+33% +$92.3K 0.16% 91
2019
Q4
$309K Buy
+918
New +$255K 0.13% 90

Other funds holding BIIB